Sublingual fentanyl orally disintegrating tablet in daily practice: efficacy, safety and tolerability in patients with breakthrough cancer pain

By ÜÜberall Michael A.   Müüller-Schwefe Gerhard H.H.  

Current Medical Research and Opinion, Vol. 27, Iss. 7, 2011-07 ,pp. : 1385-1394

Informa Healthcare

Access to resources Recommend Favorite

The use of sublingual fentanyl for breakthrough pain by using doses proportional to opioid basal regimen

By Mercadante Sebastiano   Prestia Giovanna   Casuccio Alessandra  

Current Medical Research and Opinion, Vol. 29, Iss. 11, 2013-11 ,pp. : 1527-1532

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of intranasal fentanyl spray versus other opioids for breakthrough pain in cancer

By Vissers Debby   Stam Wiro   Nolte Thomas   Lenre Malin   Jansen Jeroen  

Current Medical Research and Opinion, Vol. 26, Iss. 5, 2010-05 ,pp. : 1037-1045

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer pain

By Rauck Richard L.   Tark Marvin   Reyes Eva   Hayes Teresa G.   Bartkowiak Anthony J.   Hassman David   Nalamachu Srinivas   Derrick Rob   Howell Julian  

Current Medical Research and Opinion, Vol. 25, Iss. 12, 2009-12 ,pp. : 2877-2885

Informa Healthcare

Access to resources Recommend Favorite

Long-term effectiveness and tolerability of sublingual fentanyl orally disintegrating tablet for the treatment of breakthrough cancer pain

By Nalamachu Srinivas   Hassman David   Wallace Mark S.   Dumble Sam   Derrick Rob   Howell Julian  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 519-530

Informa Healthcare

Access to resources Recommend Favorite